DNA Aptamer LTA Detection Resolving RNA Stability Trade-offs
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
RNA aptamers for detecting lipoteichoic acid (LTA) are less stable and less tolerant of variations in solution chemistry compared to DNA aptamers, limiting their effectiveness in detecting Gram-positive bacteria.
Innovation Solution
Development of DNA aptamers with specific loop and double-stranded stem structures, capable of binding to LTA, which can be labeled with optical or electrochemical labels for detection, and their use in kits for identifying Gram-positive bacteria in medical samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If RNA aptamers are used for detecting LTA, then binding affinity can be achieved, but stability and tolerance to solution chemistry variations deteriorate
Solution Approach 1:
The patent changes the chemical composition parameter from RNA to DNA, which fundamentally alters the stability characteristics while maintaining binding capability. DNA aptamers exhibit enhanced chemical stability and resistance to degradation compared to RNA aptamers, directly resolving the stability issue while preserving LTA binding affinity
Solution Approach 2:
The patent creates a DNA version as a copy of the RNA aptamer sequence, transferring the binding function to a more stable molecular platform. This copying approach allows the aptamer to maintain its target recognition capability while gaining improved stability and tolerance to solution variations
2Reliability
If RNA aptamers are used for detecting LTA, then specific binding can be achieved, but tolerance to solution chemistry variations deteriorates
Solution Approach 1:
Changing from RNA to DNA chemistry provides broader adaptability to different solution conditions. DNA aptamers tolerate a wider range of pH levels, salt concentrations, and buffer compositions without losing binding specificity, enabling the assay to function reliably across diverse sample matrices including serum and other biological fluids
3Measurement precision
If monoclonal antibodies are used for sandwich immunoassay, then detection sensitivity can be achieved, but assay complexity and cost increase
Solution Approach 1:
The patent replaces protein-based antibodies with nucleic acid-based aptamers, creating a functional copy that performs similar binding functions. This substitution simplifies the assay system by eliminating the need for complex antibody production, purification, and validation processes while maintaining detection sensitivity
Solution Approach 2:
The patent substitutes the biological protein-based recognition system (antibodies) with a nucleic acid-based system (aptamers). This substitution enables in vitro synthesis through automated oligonucleotide synthesis, replacing complex biological manufacturing with a more controllable and scalable chemical synthesis process
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The DNA aptamers provide stable and specific binding to LTA, enabling effective detection of Gram-positive bacteria in various conditions, improving upon the limitations of RNA aptamers in terms of stability and binding affinity.
Implementation Method 1
DNA aptamers with specific loop and double-stranded stem structures, capable of binding to LTA
Data Source
AI summary
Described are a number of aptamers that are specific to bind with lipoteichoic acid (LTA), and associated methods.